María Pascual-Lucas
1PUBLICATIONS
0CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Oct 08, 2025
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study.María Pascual-Lucas, Ana María Lacosta, María Montañés
Pageof 1
